Learning Catalog Advanced Search

Search by Categories
Search in Packages
Search by Format
Search by Date Range
Products are filtered by different dates, depending on the combination of live and on-demand components that they contain, and on whether any live components are over or not.
Start
End
Search by Keyword
Sort By
  • Virtual Conference: Culture of Collaboration in Infusion Therapy

    Contains 3 Component(s), 5.00 credits offered Includes a Live Event on 11/02/2018 at 9:00 AM (EDT)

    Nurses are in the “bull’s eye” of the health care paradigm that is the “triple aim” of transformative changes in health care: improved patient satisfaction, improved outcomes, and reduction of health care costs. The transition of infusion therapy between care units and departments in the acute care setting may also need to continue to settings outside of hospital walls including home care, ambulatory care, and long-term care. The unique skill set of the infusion nurse ensures that patients and families requiring continued infusion therapy, are connected to resources that enable successful navigation through a complex system.

    CULTURE OF COLLABORATION IN INFUSION THERAPY

    Nurses are in the “bull’s eye” of the health care paradigm that is the “triple aim” of transformative changes in health care: improved patient satisfaction, improved outcomes, and reduction of health care costs. The transition of infusion therapy between care units and departments in the acute care setting may also need to continue to settings outside of hospital walls including home care, ambulatory care, and long-term care. The unique skill set of the infusion nurse ensures that patients and families requiring continued infusion therapy, are connected to resources that enable successful navigation through a complex system.

    Sponsored by: image

    Defining the Course: Care Coordination

    9:00 - 10:00 AM EST
    • Nurses play an important role in ensuring that patient care is coordinated across the care continuum
    • Collaboration and high-performance teamwork is critical
    • National call for care coordination will be examined

    Building a Culture of Safety: It Starts with Me

    10:00 - 11:00 AM EST
    • The history and state of preventable medical harm will be explored
    • Effect of hierarchal structure of patient care will be discussed
    • A case study to troubleshoot real-life solutions will be presented 

    It Happens Across the Lines: A Patient-Entered Approach

    11:00 AM - 12:00 PM EST
    • Overview of weaknesses and strengths encountered by the care coordination team
    • Patient case study that illustrates challenges in transitioning from acute to home care setting
    • Highlighting positive outcomes and developmental areas

    Having a Voice in Your Treatment

    1:30 - 2:30 PM EST
    • Treatment team is responsible for providing patient with risks and benefits
    • Patient-centered care requires the placement of the patient at the center of treatment decisions
    • Nurses must facilitate communication between the treatment team and the patient

    When Nurses Collaborate: Tactical Communication Skills

    2:30 - 3:30 PM EST
    • Session will begin with the Arudia Win-Win Conversation Model
    • Presentation of C-Suite best practices and tips to improve leadership, management, and collaborative skills 
    • Getting to the heart of challenges in ways that leave patients, family members, caregivers, and colleagues feeling respected and valued
    Contact Hours

    This entire program has been approved for 5 contact hours. Expiration date for receipt of contact hours: November 2, 2021

    CRNI® Recertifications Units

    This entire program has been approved for 10 CRNI® recertification units.
    *Note: Participants who attend the live version of this program at the 2018 National Academy in Washington, D.C. are not eligible to receive contact hours or CRNI® recertification units through this online program.

    Sessions for this One Day Program will allow attendees to explore and expand their knowledge, attitudes, and skills. This will enable them to establish strong, secure, and collaborative connections in the ever-changing health care environment.

    Defining the Course: Care Coordination

    Gerri Lamb, PhD, RN, FAAN

    9:00 – 10:00 AM EST

    Infusion nurses play an important role in helping ensure that care for patients is coordinated across the care continuum. As pivotal members of the interprofessional team, infusion nurses possess professional expertise and relationships with patients and families which are essential to care coordination outcomes. The extent to which these strengths are translated into meaningful contributions for quality and value relies heavily on collaboration and high-performance teamwork. In this presentation, the national call for care coordination and teamwork, as well as the implications for infusion nurses, are examined. Finally, how infusion nurses can take immediate action through teamwork and care coordination to improve the quality and value of health care for patients and families will be explored..

    Learning Outcomes: After the session, attendees will be able to list key issues and barriers to advancing care coordination for patients with complex chronic illnesses; examine how interprofessional team performance contributes to care coordination outcomes; and identify 3 actions infusion nurses can take to improve teamwork and care coordination.


    Building a Culture of Safety: It Starts With Me

    Cheri Constantino-Shor, MSN, RN, CRNI®, CMSRN
    10:00 - 10:00 AM EST

    This session will explore the history and contemporary state of preventable medical harm in the United States and the impact a lack of teamwork has on patient outcomes. It also will discuss the reality of the effect of the hierarchical structure of patient care and explore the changing landscape of health care and how a focus on quality has had an impact on our everyday work. A case study will help troubleshoot real-life solutions for everyday infusion challenges and will address communication barriers and strategies, while encouraging attendees to identify specific steps that can be taken to hold personal accountability for contributing to a culture of safety.

    Learning Outcomes: After the session, attendees will be able to correlate how working together can improve patient outcomes; describe 3 barriers to working together as a collaborative health care team; and discuss ways in which health care workers can function better as an efficient, interdisciplinary team.


    It Happens Across the Lines: A Patient-Centered Approach

    Daniel Heaton, PharmD, RPh
    11:00 AM - 12:00 PM EST

    This presentation will provide an overview of the weaknesses and strengths the care coordination team encounters during patient transitions of care—from inpatient to outpatient settings—for patients needing continued infusion therapy at home. Attendees will be led through a patient case study that Illustrates the challenges involved in transitioning from an acute to a home care setting. Through the case study, examples of positive outcomes and developmental areas will be highlighted, with an emphasis on how to improve communication and collaboration to provide the best possible patient care and outcomes. 

    Learning Outcomes: After the session, attendees will be able to identify barriers that are encountered during transition from inpatient to outpatient settings; describe areas that require collaboration and clarification when a patient is transitioned to infusion therapy at home or in an outpatient setting; identify communication barriers that occur between nurses and pharmacists when treating patients in a home care setting; and discuss ways in which health care professionals can collaborate to help ensure best outcomes and maximize patient comfort during difficult transitions.


    Having a Voice in Your Treatment

    Donna Wilson, MSN, RN, CBCN
    1:30 - 2:30 PM EST

    When defining treatment goals, the responsibility of the treatment team is to provide the patient with information on expected outcomes, as well as the risks and benefits of the treatment plan. Perceptions of treatment goals may differ between the treatment team and the patient. To ensure a patient’s treatment preferences are honored, shared decision-making must be person-centered and well informed. Patient-centered care requires the treatment team to place the patient at the center of treatment decisions by identifying and respecting the patient’s preferences, values, cultural traditions, and socioeconomic conditions. Nurses are in a unique position to facilitate communication between the treatment team and the patient concerning treatment options and to assist in coordinated and collaborative care, focusing not only on the physical comfort of the patient, but also on his or her emotional well-being.

    Learning Outcomes: After the session, attendees will be able to (1) identify possible differences in the perceptions of treatment goals between patients, caregivers, and clinicians; (2) describe the role of the registered nurse in collaborating on treatment decisions as a member of the treatment team; and (3) define techniques to maintain therapeutic communication between the treatment team and the patient.


    When Nurses Collaborate: Tactical Communication Skills

    Anne Collier, MPP, JD, PCC
    Cynthia Shaffer, MS, MBA, ACC
    2:30 - 3:30 PM EST

    Patient care, patient and staff safety, effective interprofessional teamwork, and staff well-being all depend on effective collaboration. Attendees will learn C-Suite best practices and tips that will noticeably improve their leadership, management, and collaborative skills. In this interactive session, we will build your collaboration skills and overall tactical communication competencies, arming you with what you need to be more effective. The session begins with the Arudia Win-Win Conversation Model, which is built on a problem-solving, rather than blame-focused, foundation. Attendees will learn how to get to the heart of the challenge in a way that leaves patients, family members, caregivers, and colleagues feeling respected and valued. Attendees will also learn the Arudia Coaching Model, the tool of choice when it comes to engaging and empowering others. When combined, these tools will help you to develop solutions that take into consideration all those affected by the outcome.

    Learning Outcomes: After the session, attendees will be able to describe ways to apply the Arudia Win-Win Conversation Model for better collaboration and patient outcomes; verbalize ways to leverage the Arudia Coaching Model to engage and gain buy-in from patients and colleagues; and acknowledge they are more confident in difficult conversations with everyone—from the patient to the provider.


    Contact Hours

    This entire program has been approved for 5 contact hours. Expiration date for receipt of contact hours: November 2, 2021

    CRNI® Recertification Units

    This entire program has been approved for 10 CRNI® recertification units.

    *Note: Participants who attend the live version of this program at the 2018 National Academy in Washington, D.C. are not eligible to receive contact hours or CRNI® recertification units through this online program.

    Gerri Lamb, PhD, RN, FAAN

    Arizona State University

    Gerri Lamb, PhD, RN, FAAN, is a professor and director of Arizona State University’s Center for Advancing Interprofessional Practice, Education, and Research. A past chair of the American Interprofessional Health Collaborative and a convener of the Arizona Nexus Innovations Network, Dr. Lamb has served as an expert consultant for many professional organizations, including the National Committee for Quality Assurance and the Agency for Healthcare Research and Quality.

    Cheri Constantino-Shor, MSN, RN, CRNI®, CMSRN

    Virginia Mason Medical Center

    Cheri Constantino-Shor, MSN, RN, CRNI®, CMSRN, is the director of clinical practice and professional development at Virginia Mason Medical Center. With more than 24 years of nursing experience, she has spoken nationally about her passion for creating a healthy work environment in health care. She is 1 of 5 nurses in the country appointed to the Academy of Medical-Surgical Nurses’ Healthy Practice Environment National Task Force.

    Daniel Heaton, PharmD, RPh

    Intermountain Healthcare

    Daniel E Heaton, PharmD, RPh, is a clinical pharmacist with Intermountain Homecare and Hospice, specializing in total parenteral nutrition, chemotherapy, and intravenous antibiotic therapy. Dr. Heaton has 15 years' experience with home infusions and collaborating with pharmacists, nurses, and doctors to create positive outcomes. He completed a training and certificate program for home infusions through the National Home Infusion Association.

    Donna Wilson, MSN, RN, CBCN

    Massey Cancer Center at Virginia Commonwealth University

    Donna M. Wilson, MSN, RN, CBCN, a certified breast care nurse, cares for oncology patients in the inpatient setting and is a patient nurse navigator in breast health at the Virginia Commonwealth University Massey Cancer Center's clinic. As a navigator, she advocates for, educates, and assists cancer patients throughout their treatment.

    Anne Collier, MPP, JD, PCC

    Arudia

    Anne E. Collier, MPP, JD, PCC, is the founder and chief executive officer of Arudia, an organization dedicated to improving culture, collaboration, and communication. In 2004, after 11 years of practicing law, she began working with organizations to help improve leadership and collaborative skills. The author of "The Workplace Toolkit—Actionable Approaches to People Problems," she has developed the Arudia System, which helps alter organizations through a combination of executive coaching, in-person workshops, webinar teleclasses, and online learning.

    Cynthia Shaffer, MS, MBA, ACC

    Arudia

    Cynthia Shaffer, MS, MBA, ACC, is practice group chair in health care at Arudia. She has 20 years’ experience in executive and management roles in health care and life sciences, including 10 years in an academic medical center. An associate certified coach through the International Coach Federation, she is a Myers Briggs Type Indicator certified practitioner, and is qualified to administer the Actualized Leader Profile and the Group Culture Profile.

  • Demystifying Gout (Part 3): Complications and Management of Chronic Gout

    Contains 1 Component(s)

    Early detection and treatment of gout is significant for reducing the risk of complications. When left untreated, gout can affect other organs and body parts causing irreversible joint damage, joint deformity, loss of mobility or range of motion, bone loss, tophi, kidney stones, chronic kidney disease, or kidney failure. This third and final podcast on demystifying gout will explore options aimed at reducing the incidence of gouty attacks, how to prevent complications, and ways to improve the patient’s quality of life.

    Early detection and treatment of gout is significant for reducing the risk of complications. When left untreated, gout can affect other organs and body parts causing irreversible joint damage, joint deformity, loss of mobility or range of motion, bone loss, tophi, kidney stones, chronic kidney disease, or kidney failure. This third and final podcast on demystifying gout will explore options aimed at reducing the incidence of gouty attacks, how to prevent complications, and ways to improve the patient’s quality of life. 

    Vickie Sayles, BSN, RN-BC, CRNI®

    Clinical Nurse Manager

    Vickie L. Sayles, BSN, RN-BC, CRNI®, is the clinical nurse manager for the department of rheumatic and immunologic diseases at the Cleveland Clinic Foundation in Cleveland, Ohio. She is board-certified in ambulatory nursing, rheumatology nursing, and infusion nursing, and she currently serves as treasurer of the Rheumatology Nurse Society. A presenter at various conferences in the United States, Ms. Sayles has spoken on subjects such as infusion nursing, infusion medications, biologic drugs, and biosimilar drugs.

    Guest:
    Vickie L. Sayles, BSN, RN-BC, CRNI®
    Clinical Nurse Manager, Department of Rheumatic and Immunologic Disease
    Cleveland Clinic Foundation

    Early detection and treatment of gout is significant for reducing the risk of complications. When left untreated, gout can affect other organs and body parts causing irreversible joint damage, joint deformity, loss of mobility or range of motion, bone loss, tophi, kidney stones, chronic kidney disease, or kidney failure. This third and final podcast on demystifying gout will explore options aimed at reducing the incidence of gouty attacks, how to prevent complications, and ways to improve the patient’s quality of life.

    Resources:     

    • Borghi C, Perez-Ruiz F. Urate lowering therapies in the treatment of gout: a systematic review and meta-analysis. Eur Rev Med Pharmacol Sci. 2016;20(5):983-992.  https://www.ncbi.nlm.nih.gov/pubmed/27010159.  Accessed September 19, 2018. 
    • Dalbeth N, Stamp LK, Merriman TR. The genetics of gout: towards personalized medicine? BMC Med. 2017;15(1):108. doi: 10.1186/s12916-017-0878-5.
    • Shekelle P, Newberry S, Fitzgerald J, et al. Management of gout: a systematic review in support of an American College of Physicians clinical practice guideline. Ann Intern Med. 2017;166(1):37-51. doi: 10.7326/M16-0461. 
    • Wagler V, Pumerantz A. Management of acute and recurrent gout. Ann Intern Med. 2017;166(10):759. doi: 10.7326/L17-0144.

  • Demystifying Gout (Part 2): Diagnosis and Management

    Contains 1 Component(s)

    The overall prevalence of gout in the United States is about 4 percent. Gout is more frequent as individuals age, and men experience the disease more often than women. Comorbidities, such as obesity, high blood pressure, heart disease, diabetes, kidney disorders, and hypocholesteremia, can increase the risk of gout. Both heredity and diet may also affect prevalence. Part 2 of this 3-part series will discuss how gout is diagnosed and provide an overview of medications used in its treatment. The podcast will conclude with the second segment discussion the continuing case study.

    The overall prevalence of gout in the United States is about 4 percent. Gout is more frequent as individuals age, and men experience the disease more often than women. Comorbidities, such as obesity, high blood pressure, heart disease, diabetes, kidney disorders, and hypocholesteremia, can increase the risk of gout. Both heredity and diet may also affect prevalence. Part 2 of this 3-part series will discuss how gout is diagnosed and provide an overview of medications used in its treatment. The podcast will conclude with the second segment discussion the continuing case study.  

    Vickie Sayles, BSN, RN-BC, CRNI®

    Clinical Nurse Manager

    Vickie L. Sayles, BSN, RN-BC, CRNI®, is the clinical nurse manager for the department of rheumatic and immunologic diseases at the Cleveland Clinic Foundation in Cleveland, Ohio. She is board-certified in ambulatory nursing, rheumatology nursing, and infusion nursing, and she currently serves as treasurer of the Rheumatology Nurse Society. A presenter at various conferences in the United States, Ms. Sayles has spoken on subjects such as infusion nursing, infusion medications, biologic drugs, and biosimilar drugs.

    Guest:
    Vickie L. Sayles, BSN, RN-BC, CRNI®
    Clinical Nurse Manager, Department of Rheumatic and Immunologic Disease
    Cleveland Clinic Foundation

    The overall prevalence of gout in the United States is about 4 percent. Gout is more frequent as individuals age, and men experience the disease more often than women. Comorbidities, such as obesity, high blood pressure, heart disease, diabetes, kidney disorders, and hypocholesteremia, can increase the risk of gout. Both heredity and diet may also affect prevalence. Part 2 of this 3-part series will discuss how gout is diagnosed and provide an overview of medications used in its treatment. The podcast will conclude with the second segment discussion the continuing case study.  

    Resources:
    1. Borghi C, Perez-Ruiz F. Urate lowering therapies in the treatment of gout:  a systematic review and meta-analysis.  Eur Rev Med Pharmacol Sci. 2016;20(5):983-992.  
    2. Dalbeth N, Stamp L, Merriman T. The genetics of gout: towards personalized medicine? BMC Med. 2017;15:108.  doi: 10.1186/s12916-017-0878-5.
    3. Shekelle P, Newberry S, Fitzgerald J, et al. Management of gout: a systematic review in support of an American College of Physicians Clinical Practice Guideline. Ann Intern Med. 2017;166(1):37-55.  doi: 10.7326/M16-0461. 
    4. Wagler VD, Pumerantz AW. Management of acute and recurrent gout. Ann Intern Med. 2017;166(10):759.  doi: 10.7326/L17-0144.

  • Demystifying Gout: Pathogenesis and Guidelines for the Management of Gout

    Contains 3 Component(s), 1.00 credit offered Recorded On: 09/19/2018

    Gout is a chronic metabolic disease experienced by approximately 4% of the population of the United States. Gout is caused by the buildup of uric acid crystals in the joints, kidneys, and other body systems, and can be debilitating for patients. Early detection of gout results in significantly fewer complications over time and reduces associated comorbidities. This presentation is designed to discuss the clinical signs and symptoms of gout, identify the triggers associated with attacks of gout, examine various treatment options, and review common complications experienced by patients with gout. This session also will explore options aimed at reducing the incidence of attacks of gout, learning how to prevent complications, and understanding ways patients with gout can improve their quality of life.

    Gout is a chronic metabolic disease experienced by approximately 4% of the population of the United States. Gout is caused by the buildup of uric acid crystals in the joints, kidneys, and other body systems, and can be debilitating for patients. Early detection of gout results in significantly fewer complications over time and reduces associated comorbidities. This presentation is designed to discuss the clinical signs and symptoms of gout, identify the triggers associated with attacks of gout, examine various treatment options, and review common complications experienced by patients with gout. This session also will explore options aimed at reducing the incidence of attacks of gout, learning how to prevent complications, and understanding ways patients with gout can improve their quality of life.

    Learning Outcomes: At the conclusion of this presentation, participants will be able to:
    • Identify the signs and symptoms of gout.
    • Discuss the triggers and current treatments for gout.
    • Verbalize complications associated with chronic gout.

    Vickie Sayles, BSN, RN-BC, CRNI®

    Clinical Nurse Manager

    Vickie L. Sayles, BSN, RN-BC, CRNI®, is the clinical nurse manager for the department of rheumatic and immunologic diseases at the Cleveland Clinic Foundation in Cleveland, Ohio. She is board-certified in ambulatory nursing, rheumatology nursing, and infusion nursing, and she currently serves as treasurer of the Rheumatology Nurse Society. A presenter at various conferences in the United States, Ms. Sayles has spoken on subjects such as infusion nursing, infusion medications, biologic drugs, and biosimilar drugs.

    CRNI® Recerts: This session has been approved for 1 CRNI® recertification unit

    Contact Hours/CE Credits: This session has been approved for 1 contact hour

    Expiration date for receipt of contact hours: September 19, 2021

  • Demystifying Gout (Part 1): Pathophysiology, Population Prevalence, and Dietary Influences

    Contains 1 Component(s)

    Gout is a relatively common form of inflammatory arthritis that causes periods of painful swelling in joints. Although it is similar in many ways to rheumatoid arthritis, it is not an autoimmune disease, but rather a metabolic disorder. In this, the first of 3 podcasts on demystifying gout, the pathophysiology of gout, population prevalence, and the role diet plays in gouty arthritis will be discussed, and the first segment in a 3-part case study will be introduced.

    Gout is a relatively common form of inflammatory arthritis that causes periods of painful swelling in joints. Although it is similar in many ways to rheumatoid arthritis, it is not an autoimmune disease, but rather a metabolic disorder. In this, the first of 3 podcasts on demystifying gout, the pathophysiology of gout, population prevalence, and the role diet plays in gouty arthritis will be discussed, and the first segment in a 3-part case study will be introduced.

    Vickie Sayles, BSN, RN-BC, CRNI®

    Clinical Nurse Manager

    Vickie L. Sayles, BSN, RN-BC, CRNI®, is the clinical nurse manager for the department of rheumatic and immunologic diseases at the Cleveland Clinic Foundation in Cleveland, Ohio. She is board-certified in ambulatory nursing, rheumatology nursing, and infusion nursing, and she currently serves as treasurer of the Rheumatology Nurse Society. A presenter at various conferences in the United States, Ms. Sayles has spoken on subjects such as infusion nursing, infusion medications, biologic drugs, and biosimilar drugs.

    Guest:
    Vickie L. Sayles, BSN, RN-BC, CRNI®
    Clinical Nurse Manager, Department of Rheumatic and Immunologic Disease
    Cleveland Clinic Foundation

    Gout is a relatively common form of inflammatory arthritis that causes periods of painful swelling in joints. Although it is similar in many ways to rheumatoid arthritis, it is not an autoimmune disease, but rather a metabolic disorder. In this, the first of 3 podcasts on demystifying gout, the pathophysiology of gout, population prevalence, and the role diet plays in gouty arthritis will be discussed, and the first segment in a 3-part case study will be introduced.

    Resources:

    • Borghi C, Perez-Ruiz F. Urate lowering therapies in the treatment of gout: a systematic review and meta-analysis.  Eur Rev Med Pharmacol Sci. 2016;20(5):983-992. Accessed 18, August 2018.
    • Dalbeth N, Stamp LK, Merriman TR. The genetics of gout: towards personalised medicine? BMC Med. 2017;15(1):108.  doi: 10.1186/s12916-017-0878-5.
    • Shekelle PG, Newberry SJ, Fitzgerald JD, et al. Management of gout:  a systematic review in support of an American College of Physicians Clinical Practice Guideline.  Ann Intern Med. 2017;166(1):37-51.  doi: 10.7326/M16-0461.
    • Wagler V, Pumerantz A. Management of acute and recurrent gout. Ann Intern Med. 2017;166(10):759.  doi: 10.7326/L17-0144.
  • What I Wish You Knew About Me: Nursing the Older Adult (Part 2)

    Contains 1 Component(s)

    According to the Pew Research Center, 10,000 baby boomers reach the age of 65 every day. It is predicted that by 2060, the number of those 85 years of age and older will more than triple. To meet the needs of this burgeoning population, it is essential that nurses be knowledgeable about best practices for geriatric patients. Some important aspects of best practices include how aging changes can increase the risk for dehydration and how changes to the integumentary and nervous systems can affect treatments and patient outcomes.

    According to the Pew Research Center, 10,000 baby boomers reach the age of 65 every day. It is predicted that by 2060, the number of those 85 years of age and older will more than triple. To meet the needs of this burgeoning population, it is essential that nurses be knowledgeable about best practices for geriatric patients. Some important aspects of best practices include how aging changes can increase the risk for dehydration and how changes to the integumentary and nervous systems can affect treatments and patient outcomes. 

    Suzanne Purvis, DNP, RN, GCNS-BC

    Clinical Nurse Specialist, Geriatrics

    Suzanne Purvis, DNP, RN, GCNS-BC, has been a geriatric clinical nurse specialist for 20 years. She obtained an MSN and a graduate certificate in gerontology from Georgia State University, and a doctor of nursing practice at the University of Minnesota. Her published work has focused on geriatric nursing competency development, the use of electronic health records in geriatrics, and dementia care education. 

    Guest: 
    Suzanne Purvis, DNP, RN, GCNS-BC
    Clinical Nurse Specialist, Geriatrics
    Beaumont Health
    Royal Oak, Michigan


    According to the Pew Research Center, 10,000 baby boomers reach the age of 65 every day. It is predicted that by 2060, the number of those 85 years of age and older will more than triple. To meet the needs of this burgeoning population, it is essential that nurses be knowledgeable about best practices for geriatric patients. Some important aspects of best practices include how aging changes can increase the risk for dehydration and how changes to the integumentary and nervous systems can affect treatments and patient outcomes. 

    Resources:
    1. Purvis S. Improving cognitive and functional outcomes in hospitalized older adults with dementia. National Association of Clinical Nurse Specialists (NACNS) 2016-2017 webinar series. November 8, 2016.
    2. Purvis S, Zupanc T. Improving assessment of pain in the cognitively impaired older adult using a pre- post-quality improvement design. Nurses Improving Care of Health System Elders 2016 Online Connect webinars. October 19, 2016.  
    3. Purvis S, Zupanc T, VanDenBergh S, Martin H. Population-based nursing competency development. J Nurs Professional Dev. 2015;31(4): 231-236.

  • Unleashing the Immune System: Treatment and Adverse Event Management for the Immuno-Oncology Patient

    Contains 3 Component(s), 1.00 credit offered Recorded On: 08/22/2018

    This presentation will discuss the clinical indications, administration, and adverse-event implications of novel immuno-oncology agents. As these therapies have emerged, it is evident that the side-effect profile and management of these agents are vastly different from traditional chemotherapy. Immuno-oncology-specific education for health care workers and patients is critical to the safe delivery and implementation of high-quality care. Throughout this presentation, the background of employing the immune system to fight cancer, and using real-patient scenarios to demonstrate best practices for infusion clinicians in the care, quality, and education of the immuno-oncology patient will be explored.

    This presentation will discuss the clinical indications, administration, and adverse-event implications of novel immuno-oncology agents. As these therapies have emerged, it is evident that the side-effect profile and management of these agents are vastly different from traditional chemotherapy. Immuno-oncology-specific education for health care workers and patients is critical to the safe delivery and implementation of high-quality care. Throughout this presentation, the background of employing the immune system to fight cancer, and using real-patient scenarios to demonstrate best practices for infusion clinicians in the care, quality, and education of the immuno-oncology patient will be explored.

    Learning Outcomes: At the conclusion of this presentation, participants will be able to:

    • Identify 3 signs and symptoms of an immune-mediated adverse event.
    • Discuss the importance of early identification and treatment of adverse events.
    • Verbalize 3 different methods of education for immuno-oncology patients.

    ​Megan Derr, MSN, RN, CMSRN, AONCS®

    Megan Derr, MSN, RN, CMSRN, AONCS®, is an oncology quality and evidence-based practice specialist at the Lehigh Valley Cancer Institute in Allentown, Pennsylvania. She is certified by the Oncology Nursing Certification Corporation as an advanced oncology clinical nurse specialist. A highlight in her current role has been educating the cancer institute about immuno-oncology agents, their side effects, and adverse event management. 

    CRNI® Recerts: This session has been approved for 1 CRNI® recertification unit

    Contact Hours/CE Credits: This session has been approved for 1 contact hour

    Expiration date for receipt of contact hours: August 22, 2021

  • What I Wish You Knew About Me: Nursing the Older Adult (Part 1)

    Contains 1 Component(s)

    Did you know older adults have more exacerbations of chronic conditions when receiving infusion therapy than younger adults? For instance, a simple antibiotic infusion in an older adult may initiate an arthritic flare. Older adults often are unable to distinguish between an acute medication reaction, symptoms of their chronic disease, or conditional effects of aging. Are you prepared to communicate and advocate for your older patients?

    Did you know older adults have more exacerbations of chronic conditions when receiving infusion therapy than younger adults? For instance, a simple antibiotic infusion in an older adult may initiate an arthritic flare. Older adults often are unable to distinguish between an acute medication reaction, symptoms of their chronic disease, or conditional effects of aging. Are you prepared to communicate and advocate for your older patients?   

    Suzanne Purvis, DNP, RN, GCNS-BC

    Clinical Nurse Specialist, Geriatrics

    Suzanne Purvis, DNP, RN, GCNS-BC, has been a geriatric clinical nurse specialist for 20 years. She obtained an MSN and a graduate certificate in gerontology from Georgia State University, and a doctor of nursing practice at the University of Minnesota. Her published work has focused on geriatric nursing competency development, the use of electronic health records in geriatrics, and dementia care education. 

    Guest: 
    Suzanne Purvis, DNP, RN, GCNS-BC
    Clinical Nurse Specialist, Geriatrics
    Beaumont Health

    Did you know older adults have more exacerbations of chronic conditions when receiving infusion therapy than younger adults? For instance, a simple antibiotic infusion in an older adult may initiate an arthritic flare. Older adults often are unable to distinguish between an acute medication reaction, symptoms of their chronic disease, or conditional effects of aging. Are you prepared to communicate and advocate for your older patients?   


    Resources:
    1. Purvis S. Improving cognitive and functional outcomes in hospitalized older adults with dementia. National Association of Clinical Nurse Specialists (NACNS) 2016-2017 webinar series. November 8, 2016.

    2. Purvis S, Zupanc T. Improving assessment of pain in the cognitively impaired older adult using a pre- post-quality improvement design. Nurses Improving Care of Health System Elders 2016 Online Connect webinars. October 19, 2016.  

    3. Purvis S, Zupanc T, VanDenBergh S, Martin H. Population-based nursing competency development. J Nurs Professional Dev. 2015;31(4): 231-236.

  • Hazardous Infusion Drug Administration in the Home Setting

    Contains 3 Component(s), 1.00 credit offered Recorded On: 07/25/2018

    Hazardous drug (HD) agents traditionally have been administered in controlled, health care settings. However, the introduction of intravenous (IV) HDs for home administration has become an area of growing concern for home care agencies and home infusion nurses. The United States Pharmacopeia (USP) has regulated the admixture and handling of HDs for controlled settings, and its role is now expanding to include all areas in the trajectory of care. Home infusion is one aspect of care that will require nursing education, policies and procedures, and appropriate personal protective equipment. Successful implementation of USP regulations will require home health infusion teams to develop a hazardous drug administration and exposure management plan to protect infusion nurses, patients and families, and the environment from toxic residue exposure.

    Hazardous drug (HD) agents traditionally have been administered in controlled, health care settings. However, the introduction of intravenous (IV) HDs for home administration has become an area of growing concern for home care agencies and home infusion nurses. The United States Pharmacopeia (USP) has regulated the admixture and handling of HDs for controlled settings, and its role is now expanding to include all areas in the trajectory of care. Home infusion is one aspect of care that will require nursing education, policies and procedures, and appropriate personal protective equipment. Successful implementation of USP <800> regulations will require home health infusion teams to develop a hazardous drug administration and exposure management plan to protect infusion nurses, patients and families, and the environment from toxic residue exposure. 

    Learning Outcomes: At the conclusion of this session, learners will be able to: 
    • Discuss the impact USP <800> will have on home infusion nurses.
    • Recognize the risks to nurses, patients and families, and the environment associated with intravenous (IV) drug residue exposure.
    • Identify necessary safety precautions when administering IV chemotherapy and other HDs in the home.
    • Review specific patient and family education that may prevent and/or reduce the risk of HD exposure in the home.

    Cynthia Huff, MSN, RN, CRNI®, OCN®, CNL

    Home Infusion Coordinator

    Cynthia Huff, MSN, RN, CRNI®, OCN®, CNL, is a home infusion coordinator at Sutter Infusion & Pharmacy Services in Sacramento, California. Her experience as an infusion and oncology nurse spans more than 20 years. Ms. Huff’s current nursing focus is to protect health care workers, patients and families, and the environment from exposure to hazardous drug residue as the administration of oral and intravenous chemotherapy increasingly takes place in patients’ homes. Ms. Huff earned a master’s degree in nursing from the University of San Francisco (USF) and recently obtained certification as a clinical nurse leader (CNL). She is currently enrolled in USF’s doctor of nursing practice degree program, with a focus on population health leadership. Her goal is to teach nursing practice.  

    Rosangel Klein, MS, RN, CNS, OCN®

    Oncology Clinical Nurse Specialist

    Rosangel Klein, MS, RN, CNS, OCN®, is the oncology clinical nurse specialist at Sutter Roseville Medical Center. She has held a number of leadership positions at Sutter Health. Most recently, she was Sutter Health Valley Area’s interim oncology service line executive and oncology service line clinical director. As service line clinical director, she was responsible for clinical integration across the continuum of care. Before this role, she served as the regional infusion center manager for Sutter Roseville Medical Center, where she worked for 4 years and was instrumental in the growth of the infusion center. She assisted in opening a new comprehensive cancer center in 2016. Ms. Klein earned a bachelor’s degree in nursing from the University of San Francisco and completed a master’s degree in oncology nursing at the University of California San Francisco.   

    Surani Kwan, MBA, MSN, NP-BC, FACHE, FAAN

    Director for Professional Practice and Nursing Excellence

    Surani Kwan, MBA, MSN, NP-BC, FACHE, FAAN, is director for professional practice and nursing excellence for Sutter Health, where she is responsible for advancing professional practice throughout system affiliates, and providing leadership in professional development, clinical education, and training for nursing and advanced practice clinicians. She was previously the executive director of operations for the Sutter Pacific Medical Foundation. Kwan has been a member of the California Association for Nurse Practitioners for nearly 20 years and served as the association’s president for 2 terms. Currently pursuing a doctorate in nursing practice at Samuel Merritt University in Oakland, California, Kwan holds a master’s of science degree in nursing and a master’s degree in business administration. She is also a certified family nurse practitioner and a Fellow of the American Association for Nurse Practitioners and the American College of Healthcare Executives.

    CRNI® Recerts: This session has been approved for 1 CRNI® recertification unit

    Contact Hours/CE Credits: This session has been approved for 1 contact hour

    Expiration date for receipt of contact hours: July 25, 2021

  • Intravenous Immunoglobulin Therapy: Treatment Approaches, Product Selection, and Administration Considerations

    Contains 3 Component(s), 1.00 credit offered Recorded On: 06/13/2018

    Intravenous immunoglobulin (IVIg) therapy is a life-saving treatment for patients with primary immune deficiency diseases. More than 75% of IVIg therapy administered in the United States is for patients with autoimmune and inflammatory diseases. However, indications for use continue to increase. In this session, we will discuss the mechanism of action of immunoglobulins, the use of IVIg therapy in certain disease states, and dosing strategies. Current standardization of product selection, approaches to dosing, and administration, which have had a positive impact on patient safety, will also be considered.

    Intravenous immunoglobulin (IVIg) therapy is a life-saving treatment for patients with primary immune deficiency diseases. More than 75% of IVIg therapy administered in the United States is for patients with autoimmune and inflammatory diseases. However, indications for use continue to increase.  In this session, we will discuss the mechanism of action of immunoglobulins, the use of IVIg therapy in certain disease states, and dosing strategies. Current standardization of product selection, approaches to dosing, and administration, which have had a positive impact on patient safety, will also be considered.  

    Learning Outcomes:  At the conclusion of this presentation, learners will be able to:

    • Verbalize 3 diagnoses for which intravenous immunoglobulin therapy is used.
    • Discuss the mechanism of action of immunoglobulins.
    • Describe approaches to dosing and administration.


    Amy Clarke, RN, IgCN

    Director of Nursing Clinical Program Services

    Amy Clarke, RN, IgCN, is the director of nursing clinical program services for Diplomat Specialty Infusion Group. Involved in specialty and home infusion services since 1994, she has performed more than 2,000 intravenous and subcutaneous infusions. Ms. Clarke has delivered numerous presentations on immunoglobulin administration, including continuing education sessions for the National Home Infusion Association and the Immunoglobulin Nursing Society (IgNS). She is the immediate past president of IgNS. 

    CRNI® Recerts: This session has been approved for 1 CRNI® recertification unit

    Contact Hours/CE Credits: This session has been approved for 1 contact hour

    Expiration date for receipt of contact hours: June 13, 2021